FALANGA ANNA

Ruolo: 
Professore straordinario a tempo determinato
Settore scientifico disciplinare: 
MALATTIE DEL SANGUE (MED/15)

Pubblicazioni

  • Leader, A., Ten Cate, V., Ten Cate-Hoek, A., Beckers, E., Spectre, G., Giaccherini, C., et al. (2020). Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 77, 86-96. Dettaglio
  • Kakkar, A., Bauersachs, R., Falanga, A., Wong, J., Kayani, G., Kahney, A., et al. (2020). Fundamental Research in Oncology and Thrombosis 2 (FRONTLINE 2): A Follow-Up Survey. THE ONCOLOGIST, 25(7), e1091-e1097. Dettaglio
  • Bikdeli, B., Madhavan, M., Gupta, A., Jimenez, D., Burton, J., Der Nigoghossian, C., et al. (2020). Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. THROMBOSIS AND HAEMOSTASIS, 120(7), 1004-1024. Dettaglio
  • Thachil, J., Tang, N., Gando, S., Falanga, A., Levi, M., Clark, C., et al. (2020). Laboratory haemostasis monitoring in COVID-19. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 18(8), 2058-2060. Dettaglio
  • Schieppati, F., Russo, L., Marchetti, M., Barcella, L., Cefis, M., Gomez-Rosas, P., et al. (2020). Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: A multi-institutional study. AMERICAN JOURNAL OF HEMATOLOGY, 95(8), 953-959. Dettaglio